Form 4 for MAIA MAIA Biotechnology, Inc.
Accepted 2022-09-01 00:00:00 ET · period of report 2022-08-30 · accession 0001127602-22-021869 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-09-01 | 2022-08-30 | MAIA | Guerrero Ramiro | Dir | P - Purchase | $3.97 | +283.31 | 288.7K | +0.1% | +$1,125 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-30 | P | A | 283.31 | $3.97 | 288,665.31 | D | — | — | (F1) These shares were purchased by the reporting person in the open market for $3.97 per share on August 30, 2022. |